QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (71) Citing Articles via Google Scholar Google Scholar Articles by Breysse, N. Articles by Amalric, M. Search for Related Content PubMed PubMed Citation Articles by Breysse, N. Articles by Amalric, M.

 Previous Article  |  Next Article 

The Journal of Neuroscience, July 1, 2002, 22(13):5669-5678

Chronic But Not Acute Treatment with a Metabotropic Glutamate 5 Receptor Antagonist Reverses the Akinetic Deficits in a Rat Model of Parkinsonism

Nathalie Breysse¹, Christelle Baunez¹, Will Spooren², Fabrizio Gasparini², and Marianne Amalric¹

¹ Laboratoire de Neurobiologie Cellulaire et Fonctionnelle, Centre National de la Recherche Scientifique, 13402 Marseille cedex 20, France, and ² Novartis Pharma AG, Basel CH-4002, Switzerland

Metabotropic glutamate receptors (mGluRs) have recently been considered as potential pharmacological targets in the treatment of neurodegenerative disorders and particularly in parkinsonism. Within the basal ganglia, receptors of group I (mGluR1 and mGluR5) are widely expressed; the present study was thus aimed at blocking these receptors in a 6-hydroxydopamine (6-OHDA) model of Parkinson's disease in the rat. Considering the prominent expression of mGluR5, we have used the selective mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) to target these receptors. In rats trained to quickly depress a lever after a visual cue, bilateral lesions of the dopaminergic nerve terminals in the striatum produced severe akinetic deficits, which were expressed by increases in delayed responses and reaction times. Acute MPEP injection (1.5, 3, and 6 mg/kg, i.p.) had no effect, whereas chronic administration, ineffective in a control group, significantly reversed the akinetic deficits. Alleviation of these deficits was seen after 1 week of treatment, and the preoperative performance was fully recovered after a 3 week treatment of MPEP at all doses. Chronic MPEP also induced ipsilateral rotation in the unilateral 6-OHDA circling model. However, no effect was seen of MPEP (1.5, 3, or 6 mg/kg, i.p.) on haloperidol-induced catalepsy (1 mg/kg, i.p.). Altogether, these results suggest a specific role of mGluRs in the regulation of extrapyramidal motor functions and a potential therapeutic value for mGluR5 antagonists in the treatment of Parkinson's disease.

Key words: basal ganglia; metabotropic receptor antagonist; 6-OHDA lesions; Parkinson's disease; reaction time task; glutamate; metabotropic receptors (mGluR5 subtype); MPEP; rat

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/22135669-10$05.00/0

This article has been cited by other articles:

				S. Lopez, N. Turle-Lorenzo, F. Acher, E. De Leonibus, A. Mele, and M. Amalric Targeting Group III Metabotropic Glutamate Receptors Produces Complex Behavioral Effects in Rodent Models of Parkinson's Disease J. Neurosci., June 20, 2007; 27(25): 6701 - 6711. [Abstract] [Full Text] [PDF]

				M. Kuwajima, M. H. Dehoff, T. Furuichi, P. F. Worley, R. A. Hall, and Y. Smith Localization and Expression of Group I Metabotropic Glutamate Receptors in the Mouse Striatum, Globus Pallidus, and Subthalamic Nucleus: Regulatory Effects of MPTP Treatment and Constitutive Homer Deletion J. Neurosci., June 6, 2007; 27(23): 6249 - 6260. [Abstract] [Full Text] [PDF]

				G. Battaglia, C. L. Busceti, G. Molinaro, F. Biagioni, A. Traficante, F. Nicoletti, and V. Bruno Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurosci., July 5, 2006; 26(27): 7222 - 7229. [Abstract] [Full Text] [PDF]

				A. Kachroo, L. R. Orlando, D. K. Grandy, J.-F. Chen, A. B. Young, and M. A. Schwarzschild Interactions between Metabotropic Glutamate 5 and Adenosine A2A Receptors in Normal and Parkinsonian Mice J. Neurosci., November 9, 2005; 25(45): 10414 - 10419. [Abstract] [Full Text] [PDF]

				R. H. P. Porter, G. Jaeschke, W. Spooren, T. M. Ballard, B. Buttelmann, S. Kolczewski, J.-U. Peters, E. Prinssen, J. Wichmann, E. Vieira, et al. Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 711 - 721. [Abstract] [Full Text] [PDF]

				B. A. McMILLEN, M. S. CRAWFORD, C. M. KULERS, and H. L. WILLIAMS EFFECTS OF A METABOTROPIC, MGLU5, GLUTAMATE RECEPTOR ANTAGONIST ON ETHANOL CONSUMPTION BY GENETIC DRINKING RATS Alcohol Alcohol., November 1, 2005; 40(6): 494 - 497. [Abstract] [Full Text] [PDF]

				E. De Leonibus, A. Oliverio, and A. Mele A study on the role of the dorsal striatum and the nucleus accumbens in allocentric and egocentric spatial memory consolidation Learn. Mem., September 1, 2005; 12(5): 491 - 503. [Abstract] [Full Text] [PDF]

				K. Naie and D. Manahan-Vaughan Regulation by Metabotropic Glutamate Receptor 5 of LTP in the Dentate Gyrus of Freely Moving Rats: Relevance for Learning and Memory Formation Cereb Cortex, February 1, 2004; 14(2): 189 - 198. [Abstract] [Full Text] [PDF]

				G. Battaglia, C. L. Busceti, G. Molinaro, F. Biagioni, M. Storto, F. Fornai, F. Nicoletti, and V. Bruno Endogenous Activation of mGlu5 Metabotropic Glutamate Receptors Contributes to the Development of Nigro-Striatal Damage Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice J. Neurosci., January 28, 2004; 24(4): 828 - 835. [Abstract] [Full Text] [PDF]

				K. Fuxe, L.F. Agnati, K. Jacobsen, J. Hillion, M. Canals, M. Torvinen, B. Tinner-Staines, W. Staines, D. Rosin, A. Terasmaa, et al. Receptor heteromerization in adenosine A2A receptor signaling: Relevance for striatal function and Parkinson's disease Neurology, December 9, 2003; 61(90116): S19 - 23. [Abstract] [Full Text]

				M. J. Marino, D. L. Williams Jr., J. A. O'Brien, O. Valenti, T. P. McDonald, M. K. Clements, R. Wang, A. G. DiLella, J. F. Hess, G. G. Kinney, et al. Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment PNAS, November 11, 2003; 100(23): 13668 - 13673. [Abstract] [Full Text] [PDF]

				P. Malherbe, N. Kratochwil, M.-T. Zenner, J. Piussi, C. Diener, C. Kratzeisen, C. Fischer, and R. H. P. Porter Mutational Analysis and Molecular Modeling of the Binding Pocket of the Metabotropic Glutamate 5 Receptor Negative Modulator 2-Methyl-6-(phenylethynyl)-pyridine Mol. Pharmacol., October 1, 2003; 64(4): 823 - 832. [Abstract] [Full Text] [PDF]

				N. Breysse, M. Amalric, and P. Salin Metabotropic Glutamate 5 Receptor Blockade Alleviates Akinesia by Normalizing Activity of Selective Basal-Ganglia Structures in Parkinsonian Rats J. Neurosci., September 10, 2003; 23(23): 8302 - 8309. [Abstract] [Full Text] [PDF]

				L. F. Agnati, S. Ferre, C. Lluis, R. Franco, and K. Fuxe Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons Pharmacol. Rev., September 1, 2003; 55(3): 509 - 550. [Abstract] [Full Text] [PDF]

				O. V. Poisik, G. Mannaioni, S. Traynelis, Y. Smith, and P. J. Conn Distinct Functional Roles of the Metabotropic Glutamate Receptors 1 and 5 in the Rat Globus Pallidus J. Neurosci., January 1, 2003; 23(1): 122 - 130. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help